You have 9 free searches left this month | for more free features.

City

Overall Status

Withdrawn (2)

No longer available (1)

Sign in for free

Phase

phase 1 (1)

phase 1/phase 2 (1)

Sponsor

National Cancer Institute (NCI) (2)

GlaxoSmithKline (1)

Collaborator

Intervention

molibresib (3)

cisplatin (1)

entinostat (1)

etoposide (1)

etoposide phosphate (1)

molibresib besylate (1)

Study Documents

Intervention Type

drug (3)

Funder Type

NIH (2)

Industry (1)

Study Type

Interventional (2)

Expanded Access (1)

molibresib

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Metastatic NUT Carcinoma, Unresectable NUT Carcinoma Trial (Cisplatin, Etoposide, Etoposide Phosphate)

Withdrawn

Metastatic NUT Carcinoma
Unresectable NUT Carcinoma

Cisplatin
+4 more

(no location specified)

Sep 25, 2020

Solid Tumours Trial (molibresib)

No longer available

Solid Tumours

molibresib

(no location specified)

Apr 9, 2020

Advanced Lymphoma, Advanced Malignant Solid Tumor, Ann Arbor Stage III B-Cell Non-Hodgkin Lymphoma Trial (Entinostat,

Withdrawn

Advanced Lymphoma
+16 more

Entinostat
Molibresib

(no location specified)

Sep 25, 2020